Bacteria persist as stowaways
Each year, bacteria of the Yersinia genus cause several thousand cases of gastrointestinal infections in Germany alone. In most cases, the human immune system manages to eliminate the bacteria. But in a fraction of the afflicted individuals, a chronic infection develops that can promote the manifestation of autoimmune diseases in the long term.
Scientists from the Helmholtz Centre for Infection Research (HZI) in Braunschweig recently discovered the trick these Yersinia germs use to hide from the immune system: They reduce the production of a toxin by means of which they promote the inflammation of the afflicted tissue during an acute infection. As a result, the inflammation subsides allowing the bacteria to escape the attention of the immune system. The researchers published their results in PLOS Pathogens.
The most widely known Yersinia germ is Yersinia pestis, the cause of the plague that can be transmitted by fleabites. Other species, such as Yersinia enterocolitica and Yersinia pseudotuberculosis, usually enter the human body via contaminated foods, for example raw pork meat, and can elicit severe diarrhoeal diseases or vomiting.
This is how the body eliminates the majority of the pathogens, while the immune system takes over the remaining clean-up work. However, a Yersinia infection can just as well become chronic and then even promote autoimmune diseases, such as reactive arthritis. But it is still unclear how the bacteria manage to survive for years inside the body without being detected by the immune system and how they promote immune reactions against a body's own tissue.
Some Yersinia strains produce a toxin called CNFY during the acute infection phase and release it into the host cells. Once inside the cells, the substance blocks cell division which, in turn, leads to a steadily increasing cell size and facilitates the attack by the pathogen. “Yersinia uses CNFY to accelerate the spread of the infection and inflammation in the tissue, which is ultimately fatal for the infected host,” says Prof Petra Dersch, who is the director of the “Molecular Infection Biology” department at the HZI.
Mice usually overcome a Yersinia infection rapidly and without being harmed. Approximately ten percent of the cases are fatal and approximately ten percent turn chronic. Petra Dersch and her team of researchers at the HZI applied state-of-the-art sequencing methods to look very closely at the mice showing a chronic course of disease and the associated Yersinia germs:
A transcriptome analysis revealed which genes in the bacteria and the mice are active and which are not. “We found the production of CNFY in the persisting, i.e. surviving, yersiniae to be down-regulated,” says Dersch. “But in the absence of CNFY, the immune system no longer detects the bacteria, the inflammatory reaction subsides and the mice survive. This trick allows the yersiniae to hide for months in the caecum (appendix) of the mice.”
Tissue analyses done by microscope also reveal a difference between yersiniae causing acute versus chronic infection: During acute infection phases, the rapidly growing bacteria produce micro-colonies that are recognised by the immune system. In contrast, the persistent bacteria are found as single cells within the tissue, which makes them more difficult to detect.
Collaborating with Dr Till Strowig, the head of the “Microbial Immune Regulation” Young Investigator group at the HZI, the scientists also showed that Yersinia pathogens can even change the microbial community in the intestines. “A Yersinia infection shifts the composition of the microbiota in the intestines in favour of inflammation-promoting bacterial species,” says Dersch.
It has been known for a long time that there is a correlation between Yersinia infections and inflammatory autoimmune diseases, such as a reactive arthritis, but the underlying mechanism is still unknown. “Our transcriptome analyses showed that the immune response to the residing bacteria in the chronically infected mice is rather inconspicuous, but still detectable,” says Petra Dersch. “Consequently, antibodies against inherent tissue might be produced since some of the surface structures of the host cells resemble those of the bacteria. This might also explain the increased manifestation of arthritis in Yersinia patients.”
In January, Petra Dersch was admitted to the European Academy of Microbiology. Founded in 2009, the Academy promotes microbiological research in Europe and aims to cross-link the scientists more closely. To this end, the Academy organises meetings and congresses and develops recommendations concerning critical issues of microbiology. The members of the Academy are renowned scientists who are elected by the Academy.
Wiebke Heine, Michael Beckstette, Ann Kathrin Heroven, Sophie Thiemann, Ulrike Heise, Aaron M. Nuss, Fabio Pisano, Till Strowig, Petra Dersch: Loss of CNFy toxin-1 induced inflammation drives Yersinia pseudotuberculosis into persistency. PLOS Pathogens, 2018, DOI: 10.1371/journal.ppat.1006858
The press release and a picture are also available on our website: https://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/bacteria_…
Helmholtz Centre for Infection Research:
Scientists at the Helmholtz Centre for Infection Research (HZI) in Braunschweig, Germany, are engaged in the study of different mechanisms of infection and of the body’s response to infection. Helping to improve the scientific community’s understanding of a given bacterium’s or virus’ pathogenicity is key to developing effective new treatments and vaccines. The HZI is a partner of the German Center for Infection Research (DZIF). http://www.helmholtz-hzi.de/en
Helmholtz Centre for Infection Research
Press and Communication
Phone: +49 531 6181-1404
All latest news from the category: Life Sciences and Chemistry
Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.
Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.
AI tailors artificial DNA for future drug development
With the help of an AI, researchers at Chalmers University of Technology, Sweden, have succeeded in designing synthetic DNA that controls the cells’ protein production. The technology can contribute to…